| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Full Paper |
1 Department of Radiology and 2 Academic Department of Obstetrics and Gynaecology, Birmingham Women's Hospital, Birmingham B15 2TG, UK
Correspondence: Dr Jo McHugo
The incidence of endometrial pathology is increased in women with tamoxifen-induced post-menopausal bleeding (PMB). The aim of this study was to determine the accuracy of transvaginal ultrasound (TVS) in diagnosing endometrial pathology in symptomatic women taking tamoxifen, using endometrial thickness measurements (5 mm and 10 mm cut-offs) and morphological changes within the uterine cavity to define abnormality. The sensitivity of TVS was 97% (95% confidence interval (CI) 83% to 100%) and the specificity 35% (95% CI 17% to 56%) at a 5 mm threshold. The corresponding likelihood ratios for a positive test were 1.47 (95% CI 1.162.10) and a negative test were 0.09 (95% CI 0.020.53). The use of a higher 10 mm threshold, characterization of endometrial morphology or combining endometrial thickness and morphology did not improve overall accuracy. TVS measurement of endometrial thickness using a 5 mm cut-off is highly accurate in excluding endometrial disease in symptomatic women taking tamoxifen and may negate the need for further diagnostic testing in women unless symptoms recur. A positive TVS result is of little value, so further testing is mandatory in order to detect benign and malignant endometrial disease associated with tamoxifen and PMB.
This article has been cited by other articles:
![]() |
J M McHugo and J Olliff Endometrial cancer Imaging, August 1, 2006; 18(1): 1 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Sherer, C. Gorelick, M. Hellmann, Y.-C. Lee, S. Angus, H. Zinn, M. Kheyman, and O. Abulafia Transvaginal sonographic findings of endometrial metastases of mammary ductal carcinoma. J. Ultrasound Med., July 1, 2006; 25(7): 917 - 920. [Full Text] [PDF] |
||||
![]() |
M. Fishman, M. Boda, E. Sheiner, J. Rotmensch, and J. Abramowicz Changes in the Sonographic Appearance of the Uterus After Discontinuation of Tamoxifen Therapy J. Ultrasound Med., April 1, 2006; 25(4): 469 - 473. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| BJR | DMFR | IMAGING | ALL BIR JOURNALS |